| | | | | |
CTKB Cytek Biosciences, Inc. Common Stock | $4,4350 | -0,11% | $621,31M | $115,19K | |
FDMT 4D Molecular Therapeutics, Inc. Common Stock | $15,7650 | +2,44% | $620,51M | $203,62K | |
EIKN Eikon Therapeutics, Inc. Common Stock | $11,8700 | +6,36% | $619,88M | $193,41K | |
| $19,0400 | -0,31% | $619,48M | $25,86K | |
| $58,8940 | -0,75% | $618,62M | $11,26K | |
EMD Western Asset Emerging Markets Debt Fund, Inc | $10,5300 | +0,29% | $618,50M | $39,66K | |
CBNK Capital Bancorp, Inc. | $36,3450 | -0,59% | $617,08M | $7,04K | |
NRDS NerdWallet, Inc. Class A Common Stock | $10,0850 | -0,54% | $616,85M | $169,11K | |
| $70,1040 | -5,72% | $616,57M | $141,60K | |
TRAX First Tracks Biotherapeutics, Inc. Ordinary Shares | $45,8550 | +5,95% | $615,50M | $108,96K | |
CGNT Cognyte Software Ltd. Ordinary Shares | $8,5000 | -0,47% | $613,97M | $49,97K | |
BWB Bridgewater Bancshares, Inc. Common Stock | $21,4700 | -0,97% | $613,72M | $6,36K | |
VINP Vinci Compass Investments Ltd. Class A Common Shares | $9,3460 | -3,25% | $613,18M | $3,17K | |
ELMT The Elmet Group Co. Common Stock | $17,7120 | +0,29% | $612,93M | $66,53K | |
| $7,2000 | +1,70% | $611,79M | $140,40K | |
